In this context, our results showed a significant increase in hippocampal BACE1, CLU, and p-tau protein levels in untreated Cu-AD rats, whereas treatment with DPZ, Vit D, and their combination resulted in significant decrements in the levels of all aforementioned AD-related biomarker. The gene discussed is MAPT; the disease is Alzheimer disease.